| With over 30 years of experience at the Food and Drug Administration, Phil has a unique combination of scientific, regulatory, clinical, and public health experience. He is a long-time supporter of CASSS and WCBP, and co-chaired the meeting several times. He is trained as a physician with board certification in internal medicine and infectious diseases and a researcher with over 100 publications on topics spanning clinical evaluation of vaccines, viral pathogenesis and immunology, and biological product development. He is currently an independent consultant, providing strategic and regulatory advice related to biological product development. He recently served as deputy director of FDA’s Office of Vaccines Research and Review, where he led assessments of biological products for evaluation and licensure and helped to oversee the development and evaluation of all vaccines authorized and licensed in the US over the past 10 years. He has also served as a key advisor to the World Health Organization, providing advice on vaccine development and evaluation, including as Chair of the WHO’s Research and Development Blueprint COVID-19 Vaccine Expert Group. |
